it's kind of inevitable that myx will bottom out at some stage soon, the accounts show that the impairments have dropped approximately $500m in net profit over the last three years. Effectively since they overpaid for generics, these losses have also pushed the market cap from a $1.3 billion company to around $5-600 million. Once these impacts are washed out, and the accounts look cleaner (not in the red) with a few other cash generating drugs in the line then a correction to moving upwards in share price to a market cap of around 7-800mill
Are we at the bottom, page-23
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.14 |
Change
-0.130(1.79%) |
Mkt cap ! $607.4M | |||
| Open | High | Low | Value | Volume |
| $7.13 | $7.16 | $7.04 | $833.5K | 117.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 650 | $7.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.14 | 431 | 1 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.09 |
Change
-0.130 ( 2.07 %) |
||||
| Open | High | Low | Volume | ||
| $7.13 | $7.16 | $7.05 | 122121 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| MYX (ASX) Chart |